Accelerate Diagnostics In...

0.71
0.01 (1.28%)
At close: Apr 01, 2025, 3:57 PM
0.71
0.00%
After-hours: Apr 01, 2025, 04:00 PM EDT

Accelerate Diagnostics Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20
Net Income -50.05M -61.62M -62.49M -77.7M -78.21M
Depreciation & Amortization 3.42M 3.25M 3M 2.52M 3M
Stock-Based Compensation 4.38M 5.39M 10.63M 22.05M 16.46M
Other Working Capital 2.94M 4.42M -335K 810K -2.58M
Other Non-Cash Items 15.46M 7.85M -2.11M 11.54M 11.17M
Deferred Income Tax n/a n/a n/a -5.63M 530K
Change in Working Capital 2.59M 4.93M 2.25M -102K -3.35M
Operating Cash Flow -24.19M -40.2M -48.73M -47.32M -50.39M
Capital Expenditures n/a -1.03M -554K -603K -1.36M
Acquisitions n/a n/a 554K 603K 1.36M
Purchase of Investments n/a n/a -27.51M -30.08M -46.93M
Sales Maturities Of Investments n/a 9.7M 40.48M 38.99M 61.9M
Other Investing Acitivies -509K -1 -554K -603K -1.36M
Investing Cash Flow -509K 8.66M 12.42M 8.3M 13.61M
Debt Repayment -1.45M 8.75M -1.28M -360K 5.21M
Common Stock Repurchased n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a
Other Financial Acitivies -1.48M -3.73M 39K 706K 6.06M
Financial Cash Flow 27.05M 9.02M 31.63M 43.23M 11.63M
Net Cash Flow 2.96M -22.77M -4.99M 4.12M -25.23M
Free Cash Flow -24.19M -41.23M -49.28M -47.93M -51.76M